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ABSTRACT 
Infection with Hepatitis B virus (HBV) is a serious public health problem worldwide, with 
over 360 million carriers. Sixty 
of 200 consented pregnant women subjects were recruited for this study to determine 
the sero-prevalence of Hepatitis B surface antigenaemia
attending antenatal clinic at General Hospital, Aliero, Kebbi State, Nigeria.
questionnaire was used for the data collection. Sera were collected and tested for 
hepatitis B surface antigen (HBsAg) using commercial rapid d
prevalence rate of 8.50% among all pregnant women studied was found.
sero-positive/negative women that attended the antenatal clinic during this study were 
found be married. On sociodemographic characteristics/ risk fa
statistical significance difference between the women with HBsAg positive sera and those 
without the infection, with respect to age group (
0.484), Economic status (P-value 
0.082) and Sharing of sharp objects (
significant difference among women base on blood transfusion(s) (p value = 0.008) and 
vaccinated (p value = 0.001). The prevalence of hepatitis 
pregnant women at General Hospital Aliero as in the high endemic zone that is more than 
7%. However the prevalence rate is lower than the national average of 11%. The 
infection has zero (0%) prevalence among the women who rec
suggest the need for improved maternal health, routine immunization HBV screening 
among pregnant women in central Nigeria.
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INTRODUCTION 
There are over 2 billion people estimated to be 
living with the hepatitis B virus globally
around 360 million are chronically infected and 
at risk of developing life-threatening liver 
disease (WHO, 2009). Sixty millions
chronically infected reside in sub-Saharan Africa. 
Up to a quarter of these chronically infected 
individuals may die as a result of the infection 
(WHO, 2009).  
Hepatitis B infection can be transmitted by 
ways. The pattern of transmission depends on 
the number of chronic carriers in the community
(Baawuga et al., 2008; Dutta, 2009)
where it is endemic such as Sub-Saharan Africa, 
transmission is mainly either vertical, from a 
carrier mother to her newborn, or through close 
contact between children (Dutta, 2009)
Perinatal transmission of HBV occurs mainly 
during or soon after delivery, through c
the infant with maternal blood and other body 
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fluids (WHO, 2006). Breast milk has not been 
implicated as a major source of vertical 
transmission but mothers who are carriers are 
encouraged not to wet-nurse other babies but 
can breast feed their own children 
Mothers who are carriers with the “e” antigen 
positive have a 90% chance of infecting their 
new born (Hadziyannis, 2011). It has been 
indicated that children infected before 1 year 
have a 90% chance of developing to chronic 
stage of the infection and only 10% of those 
infected at adulthood are likely to
chronic carriers (Hadziyannis, 2011)
suggested that the major intervention
to be taken to reduce hepatitis B infection is by 
having a wider coverage of infant vaccination 
(Mannava and Morgan, 2012)
reduces the risk of developing hepatitis B 
infection among infants of hepatitis B positive 
mothers by about 4 times (
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Several interventions have been shown to 
reduce the incidence of vertical transmission. 
These include the use of antiviral such as 
tenofovir at the third trimester - if viral load is 
more than 1 × 107 copies/ml- and vaccinating 
the child with both immunoglobulin and antigen 
soon after birth but within 24 h of birth (Celen et 
al., 2013). In the General Hospital Aliero such 
interventions are not available because there is 
no routine screening of pregnant women for 
hepatitis B infection. Even the routine dose of 
hepatitis B vaccine that is usually given a week 
after delivery is not always administered and 
babies born to infected mothers need these 
interventions hence the need for a study to 
show the burden of the problem.  
The current study aimed at determining the 
sero-prevalence of hepatitis B virus among 
pregnant women attending the antenatal clinic 
at General Hospital Aliero, Kebbi State, Nigeria. 
This will help policy makers to effectively plan to 
reduce the prevalence of hepatitis B in the study 
population. This data will also help programme 
managers and health planners, to plan 
vaccination and other preventive measures or 
strategies (Wright, 2006). It will also show the 
importance of hepatitis B Surface antigen 
screening of pregnant mothers as another 
intervention towards the reduction of hepatitis B 
transmission. 
 
MATERIALS AND METHODS 
Study location 
The study was conducted at General Hospital 
Aliero, Kebbi State, Nigeria. This is one of the 
Secondary Hospital in Kebbi with a 50-bed 
capacity. It serves people from aliero local 
government and its neighborhoods. Antenatal 
clinics are held on Tuesdays with clients 
numbering around 30 every week. The antenatal 
clients seen are normal antenatal cases as well 
as high risk obstetric patients. Every pregnant 
woman booking or continuing for antenatal care 
at the study location was counseled for Hepatitis 
B virus testing, during the study period. The pre-
testing counseling was done in groups, while the 
post-testing counseling was done individually. 
Pregnant women were evaluated by history, 
examination, and blood test for serum HBsAg 
using immunographic rapid point of care test. 
Ethical Approval 
Ethical approval to conduct this research was 
obtained on the 2nd May, 2019 with the 
reference number KB/MOH/19/007 from 
Research and Ethics Committee of the Kebbi 





This was a cross sectional study to determine 
the prevalence of the HBsAg among pregnant 
women attending antenatal clinic at General 
Hospital Aliero, Kebbi State, Nigeria. All pregnant 
women registering for ANC were recruited, 
whenever consent is given.  
Study population and duration of 
Investigation 
The study population was pregnant women 
attending antenatal clinic in the hospital. All 
mothers who came for antenatal booking were 
counseled for hepatitis B screening in addition to 
the routine screening. Those who consented to 
be a part of the study were recruited into the 
study. The study was conducted from 3rd June to 
29th August, 2019. Participants were recruited 
from the antenatal Clinic of the hospital. 
Inclusion and Exclusion criteria 
All pregnant women who came for their first visit 
to the antenatal clinic were told about the study 
and those selected were recruited if they 
consented to be a part of the study. The 
following category of women were excluded 
from the study: Any pregnant woman who 
declined to be part of the study. Any woman 
already in labour. Any woman who came for 
follow up antenatal care. Women who are not 
pregnant. 
Sample collection and Laboratory Method 
Every eligible pregnant woman was counseled 
on the objectives of the study, and consent form 
was administered after ensuring that the 
participant fully understood the concept of the 
research. The mothers were tested at the 
counseling room after 2mls of venous blood was 
collected using HBsAg rapid immune-
chromatographic test. Their results were 
discussed with them before they leave.  
Statistical Analysis 
All analyses were done using Statistical Program 
for Social Sciences (SPSS). Univariate analyses 
were done to determine the relationship 
between the HBsAg infection and associated risk 
factors. Chi square at significant level of 0.05 




Out of the 200 pregnant women screened during 
this study 17(8.5) (Table 1) were seropositive 
for HBsAg. The highest proportion of HBsAg 
seropositive women (10.2%) was recorded 
among age group 26-35 years of age (Table 2), 
there was no statistically significant differences 
between the age groups  participants that are 
seropositive for HBsAg and those who were 
negative for the virus (P value = 0.473). 
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Examination of other sociodemographic 
characteristics, shows that there were no 
significant difference found between the women 
with HBsAg sero-positivity and those without the 
infection with respect to marital status (Table 3), 
with P value = 0.899) and Education (Table 4) 
with P value = 0.484, Economic status (Table 5), 
with p value = 0.052, Number of sexual partners 
(Table 6) P value = 0.082, but a significant 
differences was demonstrated among women 
with history of multiple Blood transfusion (Table 
5), P value = 0.008; sharing of sharp objects 
(Table 8) p value = 0.001 and history of 
vaccination (Table 10) P value = 0.001).  
 
Table 1: Seroprevalence of HBsAg by Demographics & Risk Factors among women 
attending antenatal care at General Hospital Aliero, Kebbi State, Northwestern - Nigeria. 
Variables 








x2- value P-value 
Age  
14 – 25 137 12(8.8) 125(91.2) 1.50 0.473 
26 – 35 49 5(10.2) 44(89.8)   
≥ 36 14 0(0) 14()100   
Total  200 17(8.5) 183(91.5)   
X2 = 1.50, df = 2, P-value = 0.473, α2 = 0.05 
Marital status 
Single 0 0 0 NA NA 
Married 200 17(8.5) 183(91.5)   
Divorced 0 0 0   
Widowed 0 0 0   
Separated 0 0 0   
Total 200 17(8.5) 183(91.5)   
NA 
Education level 
None  86 10(11.6) 76(88.4) 2.45 0.484 
Primary 68 5(7.4) 63(92.6)   
Secondary 38 2(5.3) 36(94.7)   
Tertiary 8 0(0) 8(100)   
Total 200 17(8.5) 183(91.5)   
X2 = 2.45, df = 3, P-value = 0.484, α2 = 0.05 
Socioeconomic status 
Poor 134 15(11.2) 119(88.8) 3.79 0.052 
Rich 66 2(3.0) 64(97)   
Total 200 17(8.5) 183(91.5)   
X2 = 3.79, df = 1, P-value = 0.052, α2 = 0.05 
History of Blood Transfusion  
None 131 10(7.6) 121(92.4) 11.8 0.008 
Once 63 5(7.9) 58(92.1)   
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Variables 








x2- value P-value 
Twice 5 1(20) 4(80)   
≥ Three times 1 1(100) 0(0)   
Total 200 17(8.5) 183(91.5)   
X2 = 11.8, df = 3, P-value = 0.008, α2 = 0.05 
No. of Sexual Partners 
Single 170 12(7.1) 158(92.9) 3.03 0.082 
Multiple 30 5(16.7) 25(83.3)   
Total 200 17(8.5) 183(91.5)   
X2 = 3.03, df = 1, P-value = 0.082, α2 = 0.05 
Sharing of Sharp Objects 
Yes  168 15(8.9) 153(91.1) 11.9 0.001 
No  32 2(6.3) 30(93.7)   
Total 200 17(8.5) 183(91.5)   
X2 = 11.9, df = 1, P=value = 0.001, α2 = 0.05 
Vaccination History 
Yes  78 0(0) 78(100) 11.9 0.001 
No  122 17(13.9) 105(86.1)   
Total 200 17()8.5 183(91.5)   
X2 = 11.9, df = 1, P-value = 0.001, α2 = 0.05 
 
DISCUSSION 
The classification of high endemicity from HBV 
infection has been defined as HBsAg greater 
than 7% in an adult population (Uneke et al, 
2005). The HBsAg seropositivity of 8.5% among 
pregnant women in Aliero obtained in this study 
shows that Aliero like other areas in Nigeria is 
endemic for HBV infection. This result is in 
conformity with the similar findings of Olinger, 
(2008) who found 8.2% among pregnant 
women in Zaria, Kaduna State, Nigeria. This 
findings also coincides with the work of Juszozyk 
(2000) who reported earlier that the global 
prevalence of chronic HBV infection varies in 
order; highest Africa, Asia, West pacific (>8%) 
to intermediate (2-7%) in southern and Eastern 
Europe and lowest (< 2%) in Western Europe, 
North America and Australia. The prevalence 
rate in this study is lower than the national 
prevalence which was 11% (Baawuga et al., 
2008). Also lower than another study in Burkina 
Faso with a very high prevalence rate of 17.3% 
(Collenberg et al., 2006). Our prevalence rate is 
also far higher than some other East African 
countries such as Sudan (5.6%) (Elsheikh et al., 
2007), Uganda (4.9%) and Rwanda (2.4%) 
(Pillo et al., 2007).  
The distribution of HBV infection according to 
age indicate that the age group 26-30 years 
recorded the highest rate of infection (10.2%) 
and this could be attributed to the fact that age 
(26-30 years) are sexually active and may  have 
been carrying out unprotected sex with multiple 
partners. This prevalence, however, is at 
variance with that of other studies where the 
highest prevalent rates were reported among 
those 46 years and above studies have revealed 
that common route of HBV transmission is 
through blood transfusion and unprotected sex 
(El-Deeb et al., 2008).  
 A significance relationship was found between 
sharing of sharp objects and occurrence of the 
HBV infection (p value = 0.002). Those that 
share sharp objects had an extremely higher 
prevalence of HBV infection (8.9%), Compared 
to those who do not share (6.25%). 
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This concurs with the reports which suggests 
that sharing of sharp objects or needles is a 
possible route of HBV transmission due to its 
high infectious potential (Samuel et al., 2009).  
In the current study the chances of HBV 
infection increases with decrease of level of 
education and socioeconomic status, none 
educated women had the highest prevalence of 
11.6%, primary (7.4%). Secondary (5.3%), 
while those who attend tertiary level of 
education have the lowest (0%). This could be 
attributed to the lack of education, awareness 
about the HBV infection and good personal 
hygienic practice among uneducated individuals. 
Several studies have reported that poor hygiene 
practice and lack of awareness about HBV have 
contributed significantly to high rate of infection 
amongst populace (Kurbanov et al., 2010). The 
level of education, probably a surrogate of low 
socioeconomic status, reflects poor knowledge 
about prevention as well as poor access to 
health services, which lead to greater 
susceptibility to infection. 
On the basis of sexual partners, those with 
multiple sex partners  had  highest prevalence of 
16.7%, which could be due to the fact that , this 
group of women having sex with  multiple 
partners without any form of protection, which 
could be out of ignorance about the possible 
route of HBV  transmission. 
Married women exhibited a very high risk of HBV 
infection in our study; this finding suggests that 
acquisition of HBV infection which may be 
related to sexual lifestyle, influenced by 
possibility of sharing husband with co-wives as 
well as having unprotected sexual intercourse 
cuts across all categories of participants 
irrespective of status. This is similar to the works 
by Adegbsan-omilabu et al., (2015), where a 
significantly high prevalence of HBsAg were 
reported among the married, pregnant women 
compared to their single counter parts. 
However, a significant association was observed 
in the current study between history of blood 
transfusion and development of HBV infection (p 
value = 0.008). This high risk of infection among 
women with, past history of blood transfusion(s) 
additionally underlined the presence of non-safe 
blood transfusion screening administration 
among our health care facilities in Nigeria. In 
spite of the fact that screening for normal blood 
borne infection are drilled in Nigerian hospitals, 
more consideration should be given to include 
molecular technique (PCR) as part HBV 
screening before Blood transfusion. 
There were zero cases of hepatitis B among 
vaccinated pregnant women that participated in 
this study and this result was consistent with the 
expectation that this event is uncommon among 
vaccinated individuals and common within 
unvaccinated individuals in highly endemic 
areas. The intervention to stop vertical 
transmission can only be applied when the 
status of the pregnant woman is known. Mother-
to-child transmission can be avoided by 
vaccination of the newborn. There is an urgent 
need to vaccinate all infants born to mothers 
who are carriers of HBsAg. 
 
CONCLUSION 
The seroprevalence of HBV infection is high in 
among pregnant women in Aliero. The findings 
guide the need for routine HBV screening among 
pregnant women at some stage in antenatal 
care within the region and Nigeria. It also form a 
base for continual immunization campaign 
amongst rural/Urban pregnant women in 
Northwest and other parts of Nigeria.  
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